TY - JOUR PY - 2017 DA - 2017// TI - Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 JO - Lancet VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)32154-2 DO - 10.1016/S0140-6736(17)32154-2 ID - ref1 ER - TY - JOUR PY - 2018 DA - 2018// TI - Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 JO - Lancet Neurol VL - 17 UR - https://doi.org/10.1016/S1474-4422(18)30322-3 DO - 10.1016/S1474-4422(18)30322-3 ID - ref2 ER - TY - JOUR AU - Peck, K. R. AU - Johnson, Y. L. AU - Smitherman, T. A. PY - 2016 DA - 2016// TI - Migraine JO - Handb Clin Neurol VL - 138 UR - https://doi.org/10.1016/B978-0-12-802973-2.00016-1 DO - 10.1016/B978-0-12-802973-2.00016-1 ID - Peck2016 ER - TY - JOUR AU - Lipton, R. B. AU - Bigal, M. E. AU - Diamond, M. AU - Freitag, F. AU - Reed, M. L. AU - Stewart, W. F. PY - 2007 DA - 2007// TI - Migraine prevalence, disease burden, and the need for preventive therapy JO - Neurology VL - 68 UR - https://doi.org/10.1212/01.wnl.0000252808.97649.21 DO - 10.1212/01.wnl.0000252808.97649.21 ID - Lipton2007 ER - TY - JOUR PY - 2018 DA - 2018// TI - The international classification of headachedisorders, 3rd edition JO - Cephalalgia VL - 38 UR - https://doi.org/10.1177/0333102417738202 DO - 10.1177/0333102417738202 ID - ref5 ER - TY - JOUR AU - Giffin, N. J. AU - Ruggiero, L. AU - Lipton, R. B. AU - Silberstein, S. D. AU - Tvedskov, J. F. AU - Olesen, J. PY - 2003 DA - 2003// TI - Premonitory symptoms in migraine: an electronic diary study JO - Neurology VL - 60 UR - https://doi.org/10.1212/01.WNL.0000052998.58526.A9 DO - 10.1212/01.WNL.0000052998.58526.A9 ID - Giffin2003 ER - TY - JOUR AU - Goadsby, P. J. AU - Reuter, U. AU - Hallström, Y. AU - Broessner, G. AU - Bonner, J. H. AU - Zhang, F. PY - 2017 DA - 2017// TI - A controlled trial of erenumab for episodic migraine JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1705848 DO - 10.1056/NEJMoa1705848 ID - Goadsby2017 ER - TY - JOUR AU - Pietrobon, D. AU - Moskowitz, M. A. PY - 2013 DA - 2013// TI - Pathophysiology of migraine JO - Annu Rev Physiol VL - 75 UR - https://doi.org/10.1146/annurev-physiol-030212-183717 DO - 10.1146/annurev-physiol-030212-183717 ID - Pietrobon2013 ER - TY - STD TI - Lipton RB, Newman LC. Migraine  In: Lipton RB, Newman LC (2009) Pain Management Secrets 3rd ed. Maryland Heights: Elsevier Inc;  p 70–81 ID - ref9 ER - TY - JOUR AU - Widdess-Walsh, P. AU - Kotagal, P. AU - Jeha, L. AU - Wu, G. AU - Burgess, R. PY - 2007 DA - 2007// TI - Multiple auras. Clinical significance and pathophysiology JO - Neurol VL - 69 UR - https://doi.org/10.1212/01.wnl.0000267650.50269.5d DO - 10.1212/01.wnl.0000267650.50269.5d ID - Widdess-Walsh2007 ER - TY - JOUR PY - 2019 DA - 2019// TI - The American Headache Society position statement on integrating new migraine treatments into clinical practice JO - Headache VL - 59 ID - ref11 ER - TY - JOUR AU - Sacco, S. AU - Bendtsen, L. AU - Ashina, M. AU - Reuter, U. AU - Terwindt, G. AU - Mitsikostas, D. PY - 2019 DA - 2019// TI - Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention JO - J Headache Pain VL - 20 UR - https://doi.org/10.1186/s10194-019-0972-5 DO - 10.1186/s10194-019-0972-5 ID - Sacco2019 ER - TY - JOUR AU - Lamburu, G. AU - Andreou, A. P. AU - Guglielmetti, M. AU - Martelletti, P. PY - 2018 DA - 2018// TI - Emerging drugs for migraine treatment: an update JO - Expert Opin Emerg Drugs VL - 23 UR - https://doi.org/10.1080/14728214.2018.1552939 DO - 10.1080/14728214.2018.1552939 ID - Lamburu2018 ER - TY - JOUR AU - Dodick, D. W. AU - Ashina, M. AU - Brandes, J. L. AU - Kudrow, D. AU - Lanteri-Minet, M. AU - Osipova, V. PY - 2018 DA - 2018// TI - ARISE: a phase 3 randomized trial of erenumab for episodic migraine JO - Cephalalgia VL - 38 UR - https://doi.org/10.1177/0333102418759786 DO - 10.1177/0333102418759786 ID - Dodick2018 ER - TY - JOUR AU - Tepper, S. AU - Ashina, M. AU - Reuter, U. AU - Brandes, J. L. AU - Doležil, D. AU - Silberstein, S. PY - 2017 DA - 2017// TI - Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial JO - Lancet Neurol VL - 16 UR - https://doi.org/10.1016/S1474-4422(17)30083-2 DO - 10.1016/S1474-4422(17)30083-2 ID - Tepper2017 ER - TY - JOUR AU - Dodick, D. W. AU - Silberstein, S. D. AU - Bigal, M. E. AU - Yeung, P. P. AU - Goadsby, P. J. AU - Blankenbiller, T. PY - 2018 DA - 2018// TI - Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial JO - JAMA VL - 319 UR - https://doi.org/10.1001/jama.2018.4853 DO - 10.1001/jama.2018.4853 ID - Dodick2018 ER - TY - JOUR AU - Silberstein, S. D. AU - Dodick, D. W. AU - Bigal, M. E. AU - Yeung, P. P. AU - Goadsby, P. J. AU - Blankenbiller, T. PY - 2017 DA - 2017// TI - Fremanezumab for the preventive treatment of chronic migraine JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1709038 DO - 10.1056/NEJMoa1709038 ID - Silberstein2017 ER - TY - JOUR AU - Stauffer, V. L. AU - Dodick, D. W. AU - Zhang, Q. AU - Carter, J. N. AU - Ailani, J. AU - Conley, R. R. PY - 2018 DA - 2018// TI - Evaluation of galcanezumab for the prevention of episodic migraine: The EVOLVE-1 randomized clinical trial JO - JAMA Neurol VL - 75 UR - https://doi.org/10.1001/jamaneurol.2018.1212 DO - 10.1001/jamaneurol.2018.1212 ID - Stauffer2018 ER - TY - JOUR AU - Skljarevski, V. AU - Matharu, M. AU - Millen, B. A. AU - Ossipov, M. H. AU - Kim, B. AU - Yang, J. Y. PY - 2018 DA - 2018// TI - Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial JO - Cephalalgia VL - 38 UR - https://doi.org/10.1177/0333102418779543 DO - 10.1177/0333102418779543 ID - Skljarevski2018 ER - TY - JOUR AU - Detke, H. C. AU - Goadsby, P. J. AU - Wang, S. AU - Friedman, D. I. AU - Selzler, K. J. AU - Aurora, S. K. PY - 2018 DA - 2018// TI - Galcanezumab in chronic migraine. The randomized, double-blind, placebo-controlled REGAIN study JO - Neurology VL - 99 UR - https://doi.org/10.1212/WNL.0000000000006640 DO - 10.1212/WNL.0000000000006640 ID - Detke2018 ER - TY - JOUR AU - Ashina, M. AU - Saper, J. AU - Cady, R. AU - Schaeffler, B. A. AU - Biondi, D. M. AU - Hirman, J. PY - 2020 DA - 2020// TI - Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1) JO - Cephalalgia VL - 40 UR - https://doi.org/10.1177/0333102420905132 DO - 10.1177/0333102420905132 ID - Ashina2020 ER - TY - JOUR AU - Lipton, R. B. AU - Goadsby, P. J. AU - Smith, J. AU - Schaeffler, B. A. AU - Biondi, D. M. AU - Hirman, J. PY - 2020 DA - 2020// TI - Efficacy and safety of eptinezumab in patients with chronic migraine. PROMISE-2 JO - Neurology VL - 94 UR - https://doi.org/10.1212/WNL.0000000000009169 DO - 10.1212/WNL.0000000000009169 ID - Lipton2020 ER - TY - JOUR AU - Negro, A. AU - Martelletti, P. PY - 2019 DA - 2019// TI - Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies JO - Expert Rev Neurother VL - 19 UR - https://doi.org/10.1080/14737175.2019.1621749 DO - 10.1080/14737175.2019.1621749 ID - Negro2019 ER - TY - JOUR AU - Silberstein, S. D. AU - Rapoport, A. M. AU - Loupe, P. S. AU - Aycardi, E. AU - McDonald, M. AU - Yang, R. PY - 2019 DA - 2019// TI - The effect of beginning treatment with fremanezumab on headache and associated symptoms in the randomized phase 2 study of high frequency episodic migraine: post-hoc analyses on the first 3 weeks of treatment JO - Headache VL - 59 UR - https://doi.org/10.1111/head.13446 DO - 10.1111/head.13446 ID - Silberstein2019 ER - TY - JOUR PY - 2013 DA - 2013// TI - The international classificationof headache disorders, 3rd edition (beta version) JO - Cephalalgia VL - 33 UR - https://doi.org/10.1177/0333102413485658 DO - 10.1177/0333102413485658 ID - ref25 ER - TY - JOUR AU - Silberstein, S. D. AU - Holland, S. AU - Freitag, F. AU - Dodick, D. W. AU - Argoff, C. AU - Ashman, E. PY - 2012 DA - 2012// TI - Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society JO - Neurology VL - 78 UR - https://doi.org/10.1212/WNL.0b013e3182535d20 DO - 10.1212/WNL.0b013e3182535d20 ID - Silberstein2012 ER - TY - JOUR AU - Sakai, F. AU - Igarashi, H. PY - 1997 DA - 1997// TI - Prevalence of migraine in Japan: A nationwide survey JO - Cephalalgia VL - 17 UR - https://doi.org/10.1046/j.1468-2982.1997.1701015.x DO - 10.1046/j.1468-2982.1997.1701015.x ID - Sakai1997 ER - TY - JOUR AU - Manzoni, G. C. AU - Torelli, P. PY - 2001 DA - 2001// TI - Epidemiology of migraine JO - J Headache Pain VL - 2 UR - https://doi.org/10.1007/s101940170002 DO - 10.1007/s101940170002 ID - Manzoni2001 ER - TY - JOUR AU - Lipton, R. B. AU - Buse, D. C. AU - Saiers, J. AU - Fanning, K. M. AU - Serrano, D. AU - Reed, M. L. PY - 2013 DA - 2013// TI - Frequency and burden of headache-related nausea: Results from the American Migraine Prevalence and Prevention (AMPP) study JO - Headache VL - 53 UR - https://doi.org/10.1111/j.1526-4610.2012.02292.x DO - 10.1111/j.1526-4610.2012.02292.x ID - Lipton2013 ER - TY - JOUR AU - Hanson, L. L. AU - Ahmed, Z. AU - Katz, B. J. AU - Warner, J. E. A. AU - Crum, A. V. AU - Zhang, Y. PY - 2018 DA - 2018// TI - Patients with migraine have substantial reductions in measures of visual quality of life JO - Headache VL - 58 UR - https://doi.org/10.1111/head.13330 DO - 10.1111/head.13330 ID - Hanson2018 ER - TY - JOUR AU - Silberstein, S. D. PY - 1995 DA - 1995// TI - Migraine symptoms: Results of a survey of self-reported migraineurs JO - Headache VL - 35 UR - https://doi.org/10.1111/j.1526-4610.1995.hed3507387.x DO - 10.1111/j.1526-4610.1995.hed3507387.x ID - Silberstein1995 ER - TY - JOUR AU - Munjal, S. AU - Singh, P. AU - Reed, M. L. AU - Fanning, K. AU - Schwedt, T. J. AU - Dodick, D. W. PY - 2020 DA - 2020// TI - Most bothersome symptom in persons with migraine: results from the migraine in America Symptoms and Treatment (MAST) study JO - Headache VL - 60 UR - https://doi.org/10.1111/head.13708 DO - 10.1111/head.13708 ID - Munjal2020 ER - TY - JOUR AU - Reed, M. L. AU - Fanning, K. M. AU - Serrano, D. AU - Buse, D. C. AU - Lipton, R. B. PY - 2015 DA - 2015// TI - Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results JO - Headache VL - 55 UR - https://doi.org/10.1111/head.12450 DO - 10.1111/head.12450 ID - Reed2015 ER - TY - JOUR AU - Ailani, J. AU - Andrews, J. S. AU - Rettiganti, M. AU - Nicholson, R. A. PY - 2020 DA - 2020// TI - Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials) JO - J Headache Pain VL - 21 UR - https://doi.org/10.1186/s10194-020-01190-7 DO - 10.1186/s10194-020-01190-7 ID - Ailani2020 ER -